GB1353511A - Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity - Google Patents
Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activityInfo
- Publication number
- GB1353511A GB1353511A GB1129571*[A GB1129571A GB1353511A GB 1353511 A GB1353511 A GB 1353511A GB 1129571 A GB1129571 A GB 1129571A GB 1353511 A GB1353511 A GB 1353511A
- Authority
- GB
- United Kingdom
- Prior art keywords
- carbon atom
- asymmetric carbon
- alkyl
- sulphamoylpyrimidines
- blood sugar
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910052799 carbon Inorganic materials 0.000 title abstract 5
- 239000008280 blood Substances 0.000 title abstract 2
- 210000004369 blood Anatomy 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- WJJBIYLGJUVNJX-UHFFFAOYSA-N pyrimidine-2-sulfonamide Chemical class NS(=O)(=O)C1=NC=CC=N1 WJJBIYLGJUVNJX-UHFFFAOYSA-N 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 150000001721 carbon Chemical group 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/69—Benzenesulfonamido-pyrimidines
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE2021962A DE2021962C3 (de) | 1970-04-28 | 1970-04-28 | Blutzuckersenkende Sulfamoylpyrimidine mit asymmetrischem Kohlenstoffatom |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1353511A true GB1353511A (en) | 1974-05-22 |
Family
ID=5770301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1129571*[A Expired GB1353511A (en) | 1970-04-28 | 1971-04-26 | Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity |
Country Status (16)
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE789712R (fr) * | 1970-04-28 | 1973-04-05 | Schering Ag | Sulfamoylpyrimidines, a atome de carbone asymetrique, leur procede de preparation et leur |
JPS6088929U (ja) * | 1983-11-28 | 1985-06-18 | 五十嵐 五大 | 健康保持具 |
JPS62128478U (enrdf_load_stackoverflow) * | 1986-02-05 | 1987-08-14 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1670188A1 (de) * | 1967-02-01 | 1971-03-25 | Boehringer Mannheim Gmbh | Verfahren zur Herstellung von neuen antidiabetisch wirksamen Sulfonamiden |
DE1695855C3 (de) * | 1967-12-30 | 1979-07-12 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | 4-(5-Isobutyl-2-pyrimidinyl)-sulfonamidophenylessigsäure-(2-methoxy-5chloranilid) und dessen Salze mit physiologisch verträglichen Basen |
-
1970
- 1970-04-28 DE DE2021962A patent/DE2021962C3/de not_active Expired
-
1971
- 1971-03-15 CH CH245274A patent/CH556846A/xx not_active IP Right Cessation
- 1971-03-15 CH CH370971A patent/CH550181A/xx not_active IP Right Cessation
- 1971-03-15 CH CH245174A patent/CH568983A5/xx not_active IP Right Cessation
- 1971-04-01 YU YU809/71A patent/YU34412B/xx unknown
- 1971-04-02 ZA ZA712142A patent/ZA712142B/xx unknown
- 1971-04-02 DK DK158671AA patent/DK125324B/da unknown
- 1971-04-20 AT AT521372A patent/AT307431B/de not_active IP Right Cessation
- 1971-04-20 AT AT335971A patent/AT307421B/de not_active IP Right Cessation
- 1971-04-20 ES ES390365A patent/ES390365A1/es not_active Expired
- 1971-04-20 NO NO1456/71A patent/NO131835C/no unknown
- 1971-04-20 AT AT521272A patent/AT307430B/de not_active IP Right Cessation
- 1971-04-23 SE SE7105321A patent/SE378419B/xx unknown
- 1971-04-25 IL IL36704A patent/IL36704A/xx unknown
- 1971-04-26 GB GB1129571*[A patent/GB1353511A/en not_active Expired
- 1971-04-27 FR FR7114939A patent/FR2092102B1/fr not_active Expired
- 1971-04-28 BE BE766409A patent/BE766409A/xx unknown
- 1971-04-28 JP JP2852471A patent/JPS5516143B1/ja active Pending
- 1971-04-28 SU SU1692740A patent/SU415878A3/ru active
- 1971-04-28 SU SU1692741A patent/SU415879A3/ru active
- 1971-04-28 NL NLAANVRAGE7105835,A patent/NL170853C/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1505305A (en) | Benzcycloamide derivatives | |
IE36947B1 (en) | New esters their production and their medicinal use | |
GB1511095A (en) | Phenylacetic acid derivatives | |
GB1384031A (en) | N-substituted dihydropyridine compounds their production and their medicinal use | |
GB1394542A (en) | Optically active isomers of hydroxyamines | |
GB1435573A (en) | Indoloquinolizines | |
GB1304144A (enrdf_load_stackoverflow) | ||
GB1268951A (en) | Phenoxy-amines | |
GB1353511A (en) | Sulphamoylpyrimidines containing an asymmetric carbon atom and having a blood sugar lowering activity | |
GB1352257A (en) | Pyridyltriazoles their preparation and compositions containing them | |
GB1497729A (en) | Benzenesulphonyl ureas and process for their manufacture | |
GB1447474A (en) | Indole-2-carbaldehydes | |
GB1231250A (enrdf_load_stackoverflow) | ||
GB1361863A (en) | Piperazine derivatives their preparation and pharmaceutical compositions containing them | |
GB1421589A (en) | Salicylanilide derivatives | |
SE7408868L (enrdf_load_stackoverflow) | ||
GB1315355A (en) | Benzotriazole derivatives | |
GB1335913A (en) | Benzenesulphonyl-ureas and process for their manufacture | |
GB1353832A (en) | Sulphonium compounds of alpha-hydroxy-gamma-alkyl-mercapto butyric acid | |
IE34590B1 (en) | Phenylethanolamine derivatives | |
GB1384523A (en) | Oxime derivatives and their preparation | |
GB1503626A (en) | Substituted piperazine derivative its preparation and compositions containing it | |
GB1410275A (en) | Phenoxycarboxylic acid derivatives their preparation and compositions containing them | |
GB1380825A (en) | Thioesters | |
GB1444879A (en) | 3-acylamino-6-amino-3,4-dihydro-2-pyridones and their use as medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |